News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
A non-inferiority trial with protons doesn’t make sense – Dr. Nina Niu Sanford
Photo Nina Niu Sanford from UT Southwestern Medical Center
Jul 4, 2023, 05:30

A non-inferiority trial with protons doesn’t make sense – Dr. Nina Niu Sanford

A non-inferiority trial with protons doesn’t make sense, b/c they are much more expensive.

Need to show protons superior.

And the non-inferiority margin here is 1.53 – so PFS can be 53% worse with protons, & the study is still considered a proton win?

https://ncbi.nlm.nih.gov/pmc/articles/PMC5942581/

Source: Dr. Nina Niu Sanford / Twitter

Clinical Trails OncoDaily Oncology Proton Research
Special Coverage
Insight
Jan 25, 2025, 17:27
Insights from AUC3 by Andrea Necchi
Blog
Jan 25, 2025, 17:18
Bibi Maryam: Ryan Nipp on how focusing on PROs is helpful for patients with pancreatic cancer at ASCO GI
Blog
Jan 25, 2025, 17:17
Registration is still open for the two new courses at the Chelsea campus - The Institute of Cancer Research
Blog
Jan 25, 2025, 17:15
Five ways you can get involved this World Cancer Day - UICC
Blog
Jan 25, 2025, 17:11
Belén Garijo: My three top takeaways from the World Economic Forum 2025
Blog
Jan 25, 2025, 16:58
Wafaa Rashed: The importance of persistence in science
Blog
Jan 25, 2025, 16:55
Carmen Uscatu: What is the music beneath the words?
Blog
Jan 25, 2025, 16:50
Roupen Odabashian: How Helpcare AI is improving patient care by deploying AI agents
Science
Jan 25, 2025, 16:47
Concurrent PIK3CA mutant drives cachexia through inflammatory signaling in EGFR mutant lung cancer
Blog
Jan 25, 2025, 16:25
Melanie Schmid: 21st annual Cincinnati Golf Classic team
Science
Jan 25, 2025, 16:19
Paolo Tarantino: Evolutions in the treatment of HER2+ breast cancer
Blog
Jan 25, 2025, 15:56
No recurrences in MSS colorectal cancer with BOT/BAL neoadjuvant immunotherapy: NEST Trial updates from ASCOGI25